Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
A contract research organization (CRO) is a company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. A CRO may provide such services as biopharmaceutical development, biologic assay development, commercialization, preclinical research, clinical research, clinical trials management, and pharmacovigilance. CROs are designed to reduce costs for companies developing new medicines and drugs in niche markets. They aim to simplify entry into drug markets, and simplify development, as the need for large pharmaceutical companies to do everything ‘in house’ is now redundant.
The global CROs Services market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on CROs Services volume and value at global level, regional level and company level. From a global perspective, this report represents overall CROs Services market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of CROs Services in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their CROs Services manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Laboratory Corporation of America Holdings (Covance)
IQVIA
Syneos Health
Paraxel International Corporation
PRA Health Sciences
Pharmaceutical Product Development (PPD)
Charles River Laboratories International Inc (CRL)
ICON Public Limited Corporation
Wuxi Apptec
Medpace Holdings, Inc
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Clinical-study
Clinical-trial
Segment by Application
Large Company
Small Company
The global CROs Services market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on CROs Services volume and value at global level, regional level and company level. From a global perspective, this report represents overall CROs Services market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of CROs Services in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their CROs Services manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Laboratory Corporation of America Holdings (Covance)
IQVIA
Syneos Health
Paraxel International Corporation
PRA Health Sciences
Pharmaceutical Product Development (PPD)
Charles River Laboratories International Inc (CRL)
ICON Public Limited Corporation
Wuxi Apptec
Medpace Holdings, Inc
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Clinical-study
Clinical-trial
Segment by Application
Large Company
Small Company
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
